glp-1 and drinking alcohol reduction receptor agonists show promise in treating substance use disorders GLP-1 reduces heavy days – GLP-1 + 7 Good Reasons

Affordability improvements may expand coverage: Frdric Leblanc, a pharmacist at iA Financial, notes that insurers are "preparing for everything we need to do so that everybody benefits from a lower price, both in diabetes and eventually in weight management." Sandoz CEO Richard Saynor has described Canada as the world's second-largest GLP-1 market

Based on current data, around 50% of users discontinue within 12 months, and 70% within 24 months, explains CEO Hilel

Trop Life Sci Res

others continue to need it at a lower or unchanged dose

Tyna Moore joins the podcast again to debunk the myths and misconceptions around the class of peptides known as GLP-1 agonists

Overall, these findings promote the awareness that asthma may enhance the risk of developing brain-related conditions, along with highlighting the positive impact GLP-1RAs have on these conditions independently